Quercetin Alleviates Neuropathic Pain in the Rat CCI Model by Mediating AMPK/MAPK Pathway
Guangyao Ye,Chunyan Lin,Yu Zhang,Zihan Ma,Yuebo Chen,Lingsi Kong,Liyong Yuan,Tao Ma
DOI: https://doi.org/10.2147/JPR.S298727
IF: 2.8319
2021-05-20
Journal of Pain Research
Abstract:Guangyao Ye, 1, * Chunyan Lin, 1, * Yu Zhang, 1 Zihan Ma, 2 Yuebo Chen, 1 Lingsi Kong, 1 Liyong Yuan, 1 Tao Ma 3 1 Department of Anesthesiology, Ningbo No.6 Hospital, Ningbo, 315040, People's Republic of China; 2 School of Medicine, Ningbo University, Ningbo, 315211, People's Republic of China; 3 Department of Anesthesiology and Pharmacology, Xuzhou Medical University, Xuzhou, 221000, People's Republic of China *These authors contributed equally to this work Correspondence: Liyong Yuan Department of Anesthesiology, Ningbo No.6 Hospital, Ningbo, 315040, People's Republic of China Email Tao Ma Department of Anesthesiology and Pharmacology, Xuzhou Medical University, Xuzhou, 221000, People's Republic of China Email Context: Quercetin (que) is one abundant flavonol with a variety of biological activities. Previous studies have shown quercetin can reduce neuropathic pain in rats with chronic constriction injury (CCI). Objective: To evaluate the effects of quercetin on neuropathic pain in CCI model and explore its underlying mechanism in vivo. Materials and Methods: CCI model was established by ligating the sciatic nerve of right leg on the SD rats. They were divided into ten groups: sham group, CCI model, sham+ que, CCI+ que group (30, 60, 120 mg/kg), CCI+ AICAR, CCI+ que+ compound C, CCI+etoricoxib, and the control group. They were administered for 28 days, and were performed the mechanical withdrawal threshold (MWT) and thermal withdrawal latency (TWL) during the experiment. At the end of the experiment, sciatic nerves and spinal cord segments of rats were collected, ELISA detected the expression of inflammatory factors, detected the microglia and astrocytes with fluorescence, and Western blot detected AMPK/MAPK pathway. Results: Que could increase the MWT of CCI rats, improve the TWL of plantar, and reduce the inflammatory cells at the ligation site of the sciatic nerve. Also, que could reduce the levels of TNF-α, IL-6, and IL-1β. Western blotting results showed that p-38 MAPK, p-ERK, and p-JNK were activated in the spinal dorsal horn of CCI model group. After treatment with que and AMPK agonists, the phosphorylation levels of related proteins were inhibited. In addition, the analgesic effect of que was abolished when the AMPK inhibitor was added. Discussion and Conclusion: Quercetin alleviated the inflammatory response of sciatic nerve and spinal dorsal horn in rats induced by CCI. Quercetin alleviates neuralgia in CCI rats by activating AMPK pathway and inhibiting MAPK pathway and its downstream targets, p-38, p-ERK, and p-JNK. Keywords: quercetin, neuropathic pain, AMPK, MAPK, CCI Neuropathic pain (NPP) is a type of chronic pain which is ascribed to somatosensory nervous system damage or diseases, such as nerve compression, pathological changes, autoimmune diseases, and incisions. 1 The annual incidence of NPP is about 7–8%. 2 It is mainly manifested as spontaneous pain and hyperalgesia. The commonly used drugs in NPP's clinical treatment include antiepileptic drugs, antidepressants, and opioid analgesics, but their effects are limited, and there are many adverse reactions. 3 Therefore, it is of great significance to develop new NPP drugs with sound analgesic effects and few adverse reactions. In recent years, research on NPP's mechanism has revealed that activation of adenosine monophosphate-activated protein kinase (AMPK) could inhibit two signaling pathways which are closely related to central sensitization and changes in neuronal synaptic plasticity after nerve injury. They are the mammalian target of rapamycin (mTOR) and mitogen-activated protein kinases (MAPK), which could inhibit the occurrence and development of chronic pain. 4 MAPK is a protein serine/threonine kinase. This vital signal transduction protein receives signals from membrane receptors and carries them into the nucleus. It regulates the transcription and translation through protein phosphorylation. 5 , 6 When the MAPK family is activated, it will increase the excitability of spinal cord dorsal horn (SCDH) microglia and astrocytes. It also increases the synthesis and releases of inflammatory factors, enhances excitatory synaptic transmission, and increases neurons' excitability, central sensitization, including pain allergies and hyperalgesia allodynia, which can produce an aggravated pain response to stimuli outside the area of injury. 7 , 8 -Abstract Truncated-
clinical neurology